Skip to main content
SpringerLink
Log in

The Immunosuppressed Patient

  • Chapter
  • First Online:
Complications in Acute Care Surgery

  • 1305 Accesses

Abstract

Surgical decision making for urgent and emergency problems can be complex, and this is amplified in the immunosuppressed patient. Diagnoses and management, both operative and non-operative, require an understanding of the individual challenges and risks coupled with different types of immunosuppression, as well as broad knowledge base of the infectious and non-infectious conditions that can result in surgical disease. This chapter reviews some common acquired or induced immunocompromised conditions, the common pathogens and pathophysiology that manifests in immunocompromised patients, and treatment and prevention strategies for these acute care surgical problems in the context of the immunosuppressed individual.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hall HI, An Q, Tang T, Song R, Chen M, Green T, et al. Prevalence of diagnosed and undiagnosed HIV infection-United States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2015;64(24):657–62.

    PubMed  Google Scholar 

  2. Maartens G, Celum C, Lewin SR. HIV infection: epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–71.

    Article  PubMed  Google Scholar 

  3. Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. PsycEXTRA Dataset: American Psychological Association (APA); 2009.

    Google Scholar 

  4. Khunnawat C, Mukerji S, Havlichek D, Touma R, Abela GS. Cardiovascular manifestations in human immunodeficiency virus-infected patients. Am J Cardiol. 2008;102(5):635–42.

    Article  PubMed  Google Scholar 

  5. Hilton R. Human immunodeficiency virus infection and kidney disease. J Roy Coll Phys Edinburgh. 2013;43(3):236–40.

    Article  CAS  Google Scholar 

  6. Chu C, Selwyn PA. Complications of HIV infection: a systems-based approach. Am Fam Phys. 2011;83(4):395–406.

    Google Scholar 

  7. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, et al. Antiretroviral treatment of adult HIV infection. JAMA. 2014;312(4):410.

    Article  PubMed  CAS  Google Scholar 

  8. Hofman P, Nelson AM. The pathology induced by highly active antiretroviral therapy against human immunodeficiency virus: an update. CMC. 2006;13(26):3121–32.

    Article  CAS  Google Scholar 

  9. Littlewood KE. The immunocompromised adult patient and surgery. Best Pract Res Clin Anaesthesiol. 2008;22(3):585–609.

    Article  PubMed  Google Scholar 

  10. Hannaman MJ, Ertl MJ. Patients with immunodeficiency. Med Clin North Am. 2013;97(6):1139–59.

    Article  PubMed  Google Scholar 

  11. Saltzman DJ. The surgeon and AIDS. Arch Surg. 2005;140(10):961.

    Article  PubMed  Google Scholar 

  12. Weledji EP, Nsagha D, Chichom A, Enoworock G. Gastrointestinal surgery and the acquired immune deficiency syndrome. Ann Med Surg. 2015;4(1):36–40.

    Article  Google Scholar 

  13. Deneve JL, Shantha JG, Page AJ, Wyrzykowski AD, Rozycki GS, Feliciano DV. CD4 count is predictive of outcome in HIV-positive patients undergoing abdominal operations. Am J Surg. 2010;200(6):694–700.

    Article  PubMed  Google Scholar 

  14. King JT Jr, Perkal MF, Rosenthal RA, Gordon AJ, Crystal S, Rodriguez-Barradas MC, et al. Thirty-day postoperative mortality among individuals with HIV infection receiving antiretroviral therapy and procedure-matched, uninfected comparators. JAMA Surg. 2015;150(4):343–51.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Tran HS, Moncure M, Tarnoff M, Goodman M, Puc MM, Kroon D, et al. Predictors of operative outcome in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. Am J Surg. 2000;180(3):228–33.

    Article  CAS  PubMed  Google Scholar 

  16. Cancer. 2014;120(14).

    Google Scholar 

  17. Sahai SK. Perioperative assessment of the cancer patient. Best Pract Res Clin Anaesthesiol. 2013;27(4):465–80.

    Article  PubMed  Google Scholar 

  18. Desai DM, Kuo PC. Perioperative management of special populations: immunocompromised host (cancer, HIV, transplantation). Surg Clin North Am. 2005;85(6):1267–82.

    Article  PubMed  Google Scholar 

  19. Steele TA. Chemotherapy-induced immunosuppression and reconstitution of immune function. Leuk Res. 2002;26(4):411–4.

    Article  CAS  PubMed  Google Scholar 

  20. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, et al. Executive summary: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis. 2011;52(4):427–31.

    Article  PubMed  Google Scholar 

  21. Nishimoto N. Cytokine signal regulation and autoimmune disorders. Autoimmunity. 2005;38(5):359–67.

    Article  CAS  PubMed  Google Scholar 

  22. Zola H. Human leukocyte differentiation antigens as therapeutic targets: the CD molecules and CD antibodies. Expert Opin Biol Ther. 2001;1(3):375–83.

    Article  CAS  PubMed  Google Scholar 

  23. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 2012;64(5):625–39.

    Article  CAS  Google Scholar 

  24. Rosman Z, Shoenfeld Y, Zandman-Goddard G. Biologic therapy for autoimmune diseases: an update. BMC Med. 2013;11(1):88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Doran MF, Crowson CS, Pond GR, O’Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002;46(9):2294–300.

    Article  PubMed  Google Scholar 

  26. Organ procurement and transplantation network and scientific registry of transplant recipients 2010 data report. Am J Transplant. 2011;12:1–156.

    Google Scholar 

  27. Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84(3):304–15.

    Article  CAS  PubMed  Google Scholar 

  28. Settipane GA, Pudupakkam RK, McGowan JH. Corticosteroid effect on immunoglobulins. J Allergy Clin Immunol. 1978;62(3):162–6.

    Article  CAS  PubMed  Google Scholar 

  29. Naesens M, Kuypers DRJ, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009.

    Google Scholar 

  30. Gijtenbeek JMM, van den Bent MJ, Vecht CJ. Cyclosporine neurotoxicity: a review. J Neurol. 1999;246(5):339–46.

    Article  CAS  PubMed  Google Scholar 

  31. Danovitch GM. Immunosuppressant-induced metabolic toxicities. Transpl Rev. 2000;14(2):65–81.

    Article  Google Scholar 

  32. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut. 1993;34(8):1081–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Nashan B, Citterio F. Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation. Transpl J. 2012;94(6):547–61.

    Article  CAS  Google Scholar 

  34. Helderman JH, Goral S. Gastrointestinal complications of transplant immunosuppression. J Am Soc Nephrol. 2002;13(1):277–87.

    PubMed  Google Scholar 

  35. Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, et al. Late-onset invasive aspergillosis in organ transplant recipients in the current era. Med Mycol. 2006;44(5):445–9.

    Article  CAS  PubMed  Google Scholar 

  36. Keckich DW, Blair JE, Vikram HR, Seville MT, Kusne S. Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipients. Transplantation. 2011;92(1):88–93.

    Article  PubMed  Google Scholar 

  37. Euvrard S. External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol. 1997;133(2):175–8.

    Article  CAS  PubMed  Google Scholar 

  38. Hodson EM, Barclay PG, Craig JC, Jones C, Kable K, Strippoli GFM, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev Wiley-Blackwell. 1996.

    Google Scholar 

  39. Shamberger RC, Weinstein HJ, Delorey MJ, Levey RH. The medical and surgical management of typhlitis in children with acute nonlymphocytic (myelogenous) leukemia. Cancer. 1986;57(3):603–9.

    Article  CAS  PubMed  Google Scholar 

  40. Amromin GD. Necrotizing enteropathy. JAMA. 1962;182(1):23.

    Article  CAS  PubMed  Google Scholar 

  41. Gorschluter M, Mey U, Strehl J, Ziske C, Schepke M, Schmidt-Wolf IGH, et al. Neutropenic enterocolitis in adults: systematic analysis of evidence quality. Eur J Haematol. 2005;75(1):1–13.

    Article  PubMed  Google Scholar 

  42. Urbach DR, Rotstein OD. Typhlitis. Can J Surg. 1999;42(6):415–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Glenn J, Funkhouser WK, Schneider PS. Acute illnesses necessitating urgent abdominal surgery in neutropenic cancer patients: description of 14 cases and review of the literature. Surgery. 1989;105(6):778–89.

    CAS  PubMed  Google Scholar 

  44. Ullery BW, Pieracci FM, Rodney JRM, Barie PS. Neutropenic enterocolitis. Surg Infect. 2009;10(3):307–14.

    Article  Google Scholar 

  45. T-f Hsu, Huang H-H, Yen DH-T, Kao W-F, Chen J-D, Wang L-M, et al. ED presentation of neutropenic enterocolitis in adult patients with acute leukemia. Am J Emerg Med. 2004;22(4):276–9.

    Article  Google Scholar 

  46. Cardona AF, Ramos PL, Casasbuenas A. From case reports to systematic reviews in neutropenic enterocolitis. Eur J Haematol. 2005;75(5):445–6.

    Article  PubMed  Google Scholar 

  47. Frick MP, Maile CW, Crass, Goldberg ME, Delaney JP. Computed tomography of neutropenic colitis. Am J Roentgenol. 1984;143(4):763–5.

    Google Scholar 

  48. Dietrich CF, Hermann S, Klein S, Braden B. Sonographic signs of neutropenic enterocolitis. World J Gastroenterol. 2006;12(9):1397–402.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American society of clinical oncology growth factors expert panel. J Clin Oncol. 2000;18(20):3558–85.

    CAS  PubMed  Google Scholar 

  50. Wade DS. Abdominal pain in neutropenic patients. Arch Surg. 1990;125(9):1119.

    Article  CAS  PubMed  Google Scholar 

  51. Badgwell BD, Cormier JN, Wray CJ, Borthakur G, Qiao W, Rolston KV, et al. Challenges in surgical management of abdominal pain in the neutropenic cancer patient. Ann Surg. 2008;248(1):104–9.

    Article  PubMed  Google Scholar 

  52. Machado NO. Neutropenic enterocolitis: a continuing medical and surgical challenge. North Am J Med Sci. 2010;2(7):293–300.

    Google Scholar 

  53. Boppana SB, Fowler KB. Persistence in the population: epidemiology and transmisson. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, et al., editors. Human Herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press Copyright (c) Cambridge University Press 2007; 2007.

    Google Scholar 

  54. Baroco AL, Oldfield EC. Gastrointestinal cytomegalovirus disease in the immunocompromised patient. Curr Gastroenterol Rep. 2008;10(4):409–16.

    Article  PubMed  Google Scholar 

  55. Razonable RR. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients. Infect Dis Clin North Am. 2013;27(2):317–42.

    Article  PubMed  Google Scholar 

  56. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, et al. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer. 2005;41(15):2268–79.

    Article  PubMed  Google Scholar 

  57. Kandiel A, Lashner B. Cytomegalovirus colitis complicating inflammatory bowel disease. Am J Gastroenterol. 2006;101(12):2857–65.

    Article  CAS  PubMed  Google Scholar 

  58. Peter A, Telkes G, Varga M, Sarvary E, Kovalszky I. Endoscopic diagnosis of cytomegalovirus infection of upper gastrointestinal tract in solid organ transplant recipients: hungarian single-center experience. Clin Transpl. 2004;18(5):580–4.

    Article  Google Scholar 

  59. Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96(4):333–60.

    Article  CAS  PubMed  Google Scholar 

  60. Murray JG, Evans SJ, Jeffrey PB, Halvorsen RA. Cytomegalovirus colitis in AIDS: CT features. Am J Roentgenol. 1995;165(1):67–71.

    Article  CAS  Google Scholar 

  61. Morunglav M, Theate I, Bertin G, Hantson P. CMV enteritis causing massive intestinal hemorrhage in an elderly patient. Case Report Med. 2010;2010:1–4.

    Article  Google Scholar 

  62. Michalopoulos N, Triantafillopoulou K, Beretouli E, Laskou S, Papavramidis TS, Pliakos I, et al. Small bowel perforation due to CMV enteritis infection in an HIV-positive patient. BMC Res Notes. 2013;6(1):45.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Wang HW, Kuo CJ, Lin WR, Hsu CM, Ho YP, Lin CJ, et al. The clinical characteristics and manifestations of cytomegalovirus esophagitis. Dis Esophagus. 2015;n/a-n/a.

    Google Scholar 

  64. Tan BH. Cytomegalovirus treatment. Curr Treat Options Infect Dis. 2014;6(3):256–70.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kram HB, Shoemaker WC. Intestinal perforation due to cytomegalovirus infection in patients with AIDS. Dis Colon Rectum. 1990;33(12):1037–40.

    Article  CAS  PubMed  Google Scholar 

  66. Wexner SD, Smithy WB, Trillo C, Hopkins SB, Dailey TH. Emergency colectomy for cytomegalovirus ileocolitis in patients with the acquired immune deficiency syndrome. Dis Colon Rectum. 1988;31(10):755–61.

    Article  CAS  PubMed  Google Scholar 

  67. Arnold M, Itzikowitz R, Young B, Machoki SM, Hsiao NY, Pillay K, et al. Surgical manifestations of gastrointestinal cytomegalovirus infection in children: clinical audit and literature review. J Pediatr Surg. 2015.

    Google Scholar 

  68. Lessa FC, Mu Y, Bamberg WM, Beldavs ZG, Dumyati GK, Dunn JR, et al. Burden of clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–34.

    Article  CAS  PubMed  Google Scholar 

  69. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A, Minton NP. The role of toxin A and toxin B in clostridium difficile infection. Nature. 2010;467(7316):711–3.

    Article  CAS  PubMed  Google Scholar 

  70. Jiang ZD, Garey KW, Price M, Graham G, Okhuysen P, Dao-Tran T, et al. Association of Interleukin-8 polymorphism and immunoglobulin G anti-toxin A in patients with clostridium difficile–associated diarrhea. Clin Gastroenterol Hepatol. 2007;5(8):964–8.

    Article  CAS  PubMed  Google Scholar 

  71. Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK. Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol. 2012;107(7):1011–9.

    Article  CAS  PubMed  Google Scholar 

  72. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98.

    Article  CAS  PubMed  Google Scholar 

  73. Fujitani S, George WL, Murthy AR. Comparison of clinical severity score indices for Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):220–8.

    Article  PubMed  Google Scholar 

  74. Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, et al. WSES guidelines for management of clostridium difficile infection in surgical patients. World J Emerg Surg. 2015;10(1).

    Google Scholar 

  75. Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12(4):281–9.

    Article  CAS  PubMed  Google Scholar 

  76. Farooq PD, Urrunaga NH, Tang DM, von Rosenvinge EC. Pseudomembranous colitis. Dis Mon. 2015;61(5):181–206.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Valiquette L, Pépin J, Do XV, Nault V, Beaulieu AA, Bédard J, et al. Prediction of complicated clostridium difficile infection by pleural effusion and increased wall thickness on computed tomography. Clin Infect Dis. 2009;49(4):554–60.

    Article  PubMed  Google Scholar 

  78. Barbut F, Petit JC. Epidemiology of clostridium difficile-associated infections. Clin Microbiol Infect. 2001;7(8):405–10.

    Article  CAS  PubMed  Google Scholar 

  79. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, et al. Treating clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9(12):1044–9.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Kelly CR, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A, et al. Fecal microbiota transplant for treatment of clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014;109(7):1065–71.

    Article  PubMed  Google Scholar 

  81. Neal MD, Alverdy JC, Hall DE, Simmons RL, Zuckerbraun BS. Diverting loop ileostomy and colonic lavage. Ann Surg. 2011;254(3):423–9.

    Article  PubMed  Google Scholar 

  82. Lee DY, Chung EL, Guend H, Whelan RL, Wedderburn RV, Rose KM. Predictors of mortality after emergency colectomy for clostridium difficile colitis. Ann Surg. 2014;259(1):148–56.

    Article  PubMed  Google Scholar 

  83. Cohen Stuart H, Gerding Dale N, Johnson S, Kelly Ciaran P, Loo Vivian G, McDonald LC, et al. Clinical practice guidelines for clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31(5):431–55.

    Google Scholar 

  84. Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Buisson CB. Contamination of healthcare workers’ hands with clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol. 2014;35(01):10–5.

    Article  CAS  PubMed  Google Scholar 

  85. Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis. 2013;26(4):332–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Polage CR, Solnick JV, Cohen SH. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis. 2012;55(7):982–9.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Le Loir Y, Baron F, Gautier M. Staphylococcus aureus and food poisoning. Genet Mol Res. 2003;2(1):63–76.

    PubMed  Google Scholar 

  88. Flemming K, Ackermann G. Prevalence of enterotoxin producing staphylococcus aureus in stools of patients with nosocomial diarrhea. Infection. 2007;35(5):356–8.

    Article  CAS  PubMed  Google Scholar 

  89. Boyce JM, Havill NL. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant staphylococcus aureus. Am J Gastroenterol. 2005;100(8):1828–34.

    Article  PubMed  Google Scholar 

  90. Gorkiewicz G. Nosocomial and antibiotic-associated diarrhoea caused by organisms other than Clostridium difficile. Int J Antimicrob Agents. 2009;33:S37–41.

    Article  CAS  PubMed  Google Scholar 

  91. Högenauer C, Langner C, Beubler E, Lippe IT, Schicho R, Gorkiewicz G, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355(23):2418–26.

    Article  PubMed  Google Scholar 

  92. Fakir M, Wong T, Toupance O, Lavaud S, Wynckel A, Chanard J. Yersinia enterocolitica septicemia in a renal transplant recipient on oral iron supplementation. Transplantation. 1995;60(2):206–8.

    Article  CAS  PubMed  Google Scholar 

  93. Anane S, Attouchi H. Microsporidiosis: epidemiology, clinical data and therapy. Gastroenterol Clin Biol. 2010;34(8–9):450–64.

    Article  CAS  PubMed  Google Scholar 

  94. Didier ES, Weiss LM. Microsporidiosis. Curr Opin Infect Dis. 2011;24(5):490–5.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Champion L, Durrbach A, Lang P, Delahousse M, Chauvet C, Sarfati C, et al. Fumagillin for treatment of intestinal microsporidiosis in renal transplant recipients. Am J Transpl. 2010;10(8):1925–30.

    Article  CAS  Google Scholar 

  96. Le M, Ravin K, Hasan A, Clauss H, Muchant DG, Pasko JK, et al. Single donor-derived strongyloidiasis in three solid organ transplant recipients: case series and review of the literature. Am J Transpl. 2014;14(5):1199–206.

    Article  CAS  Google Scholar 

  97. Stabile BE, Smith BR, Weeks DL. Helicobacter pylori infection and surgical disease—part I. Curr Probl Surg. 2005;42(11):756–89.

    Article  PubMed  Google Scholar 

  98. Ueda Y, Chiba T. Helicobacter pylori in solid-organ transplant recipient. Curr Opinion Organ Transpl. 2008;13(6):586–91.

    Article  Google Scholar 

  99. Chey WD, Wong BC. American college of gastroenterology guideline on the management of helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808–25.

    Article  CAS  PubMed  Google Scholar 

  100. Lavery EA, Coyle WJ. Herpes simplex virus and the alimentary tract. Curr Gastroenterol Rep. 2008;10(4):417–23.

    Article  PubMed  Google Scholar 

  101. Steiner I, Kennedy PGE, Pachner AR. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 2007;6(11):1015–28.

    Article  CAS  PubMed  Google Scholar 

  102. Vazquez J. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV. 2010;89.

    Google Scholar 

  103. Kanda N, Yasuba H, Takahashi T, Mizuhara Y, Yamazaki S, Imada Y, et al. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol. 2003;98(10):2146–8.

    Article  CAS  PubMed  Google Scholar 

  104. Samonis G, Skordilis P, Maraki S, Datseris G, Toloudis P, Chatzinikolaou I, et al. Oropharyngeal candidiasis as a marker for esophageal candidiasis in patients with cancer. Clin Infect Dis. 1998;27(2):283–6.

    Article  CAS  PubMed  Google Scholar 

  105. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev. 1997;10(1):86–124.

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Wong RCK, Abdul-Karim FW. Atypical herpes simplex esophagitis. Gastrointest Endosc. 2005;61(2):291–2.

    Article  PubMed  Google Scholar 

  107. Brady RC, Bernstein DI. Treatment of herpes simplex virus infections. Antiviral Res. 2004;61(2):73–81.

    Article  CAS  PubMed  Google Scholar 

  108. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29(6Q):15–8.

    Article  CAS  PubMed  Google Scholar 

  109. Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol. 2009;10(6):559–68.

    Article  CAS  PubMed  Google Scholar 

  110. Kozloff M, Yood MU, Berlin J, Flynn PJ, Kabbinavar FF, Purdie DM, et al. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist. 2009;14(9):862–70.

    Article  CAS  PubMed  Google Scholar 

  111. Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014;59(2):e10–52.

    Article  PubMed  Google Scholar 

  112. Guhl G, García-Díez A. Subcutaneous sweet syndrome. Dermatol Clin. 2008;26(4):541–51.

    Article  PubMed  Google Scholar 

  113. Sartelli M, Malangoni MA, May AK, Viale P, Kao LS, Catena F, et al. World society of emergency surgery (WSES) guidelines for management of skin and soft tissue infections. World J Emerg Surg. 2014;9(1):57.

    Article  PubMed  PubMed Central  Google Scholar 

  114. McGillicuddy EA, Lischuk AW, Schuster KM, Kaplan LJ, Maung A, Lui FY, et al. Development of a computed tomography-based scoring system for necrotizing soft-tissue infections. J Trauma Inj Infect Crit Care. 2011;70(4):894–9.

    Article  Google Scholar 

  115. Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014;51(8):344–62.

    Article  PubMed  PubMed Central  Google Scholar 

  116. Keung EZ, Liu X, Nuzhad A, Adams C, Ashley SW, Askari R. Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013;148(5):419.

    Article  PubMed  Google Scholar 

  117. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem. Ann Surg. 1994;219(4):416–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  118. Kelly K, Domajnko B. Perioperative stress-dose steroids. Clin Colon Rectal Surg. 2013;26(03):163–7.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Axelrod L. Perioperative management of patients treated with glucocorticoids. Endocrinol Metab Clin North Am. 2003;32(2):367–83.

    Article  CAS  PubMed  Google Scholar 

  120. Wei L, MacDonald TM, Walker BR. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med. 2004;141(10):764–70.

    Article  PubMed  Google Scholar 

  121. Chang MI, Cohen BL, Greenstein AJ. A review of the impact of biologics on surgical complications in crohnʼs disease. Inflamm Bowel Dis. 2015;1.

    Google Scholar 

  122. Mushtaq S, Goodman SM, Scanzello CR. Perioperative management of biologic agents used in treatment of rheumatoid arthritis. Am J Ther. 2011;18(5):426–34.

    Article  PubMed  Google Scholar 

  123. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control. 1999;27(2):97–132; quiz 3–4; discussion 96.

    Google Scholar 

  124. Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–6.

    PubMed  PubMed Central  Google Scholar 

  125. Guinan JL, McGuckin M, Nowell PC. Management of health-care--associated infections in the oncology patient. Oncology (Williston Park, NY). 2003;17(3):415–20; discussion 23–6.

    Google Scholar 

  126. Harris AD, Fleming B, Bromberg JS, Rock P, Nkonge G, Emerick M, et al. Surgical site infection after renal transplantation. Infect Control Hosp Epidemiol. 2015;36(4):417–23.

    Article  PubMed  PubMed Central  Google Scholar 

  127. Zhang L, Liu BC, Zhang XY, Li L, Xia XJ, Guo RZ. Prevention and treatment of surgical site infection in HIV-infected patients. BMC Infect Dis. 2012;12:115.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Coleman JS, Green I, Scheib S, Sewell C, Lee JM, Anderson J. Surgical site infections after hysterectomy among HIV-infected women in the HAART era: a single institution’s experience from 1999–2012. Am J Obstet Gynecol. 2014;210(2):117.e1–7.

    Google Scholar 

  129. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11(6):954–63.

    Article  CAS  PubMed  Google Scholar 

  130. Slieker JC, Komen N, Mannaerts GH, Karsten TM, Willemsen P, Murawska M, et al. Long-term and perioperative corticosteroids in anastomotic leakage: a prospective study of 259 left-sided colorectal anastomoses. Arch Surg. 2012;147(5):447–52.

    Article  PubMed  Google Scholar 

  131. Eriksen TF, Lassen CB, Gogenur I. Treatment with corticosteroids and the risk of anastomotic leakage following lower gastrointestinal surgery: a literature survey. Colorectal Dis. 2014;16(5):O154–60.

    Article  CAS  PubMed  Google Scholar 

  132. Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013;206(3):410–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, University of Pittsburgh, 200 Lothrop St., F1200 PUH, Pittsburgh, PA, 15213, USA

    Sergio E. Hernandez, Eric W. Etchill & Brian S. Zuckerbraun

  2. VA Pittsburgh Healthcare System, Pittsburgh, PA, USA

    Brian S. Zuckerbraun

Authors
  1. Sergio E. Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric W. Etchill
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian S. Zuckerbraun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Brian S. Zuckerbraun .

Editor information

Editors and Affiliations

  1. R Adams Cowley Shock Trauma Center Acute Care Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA

    Jose J. Diaz

  2. Acute Care Surgery, John Hopkins Hospital Acute Care Surgery, Baltimore, Maryland, USA

    David T. Efron

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Hernandez, S.E., Etchill, E.W., Zuckerbraun, B.S. (2017). The Immunosuppressed Patient. In: Diaz, J., Efron, D. (eds) Complications in Acute Care Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-42376-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42376-0_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42374-6

  • Online ISBN: 978-3-319-42376-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation